These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 16083519

  • 1. Part III: the convenience of, and patient preference for, zolmitriptan orally disintegrating tablet.
    Dowson AJ, Almqvist P.
    Curr Med Res Opin; 2005; 21 Suppl 3():S13-7. PubMed ID: 16083519
    [Abstract] [Full Text] [Related]

  • 2. Patients with migraine prefer zolmitriptan orally disintegrating tablet to sumatriptan conventional oral tablet.
    Dowson AJ, Charlesworth BR.
    Int J Clin Pract; 2003 Sep; 57(7):573-6. PubMed ID: 14529055
    [Abstract] [Full Text] [Related]

  • 3. Part IV: effects of zolmitriptan orally disintegrating tablet on migraine symptoms and ability to perform normal activities: a post-marketing surveillance study in Germany.
    Diener HC, Gendolla A.
    Curr Med Res Opin; 2005 Sep; 21 Suppl 3():S18-24. PubMed ID: 16083520
    [Abstract] [Full Text] [Related]

  • 4. Patient preference for triptan formulations: a prospective study with zolmitriptan.
    Dowson A, Bundy M, Salt R, Kilminster S.
    Headache; 2007 Sep; 47(8):1144-51. PubMed ID: 17883519
    [Abstract] [Full Text] [Related]

  • 5. Part II: clinical efficacy and tolerability of zolmitriptan orally disintegrating tablet in the acute treatment of migraine.
    Loder EW, Dowson AJ, Spierings EL.
    Curr Med Res Opin; 2005 Sep; 21 Suppl 3():S8-12. PubMed ID: 16083518
    [Abstract] [Full Text] [Related]

  • 6. Rizatriptan. Convenience and consistency.
    Evans RW.
    Postgrad Med; 2000 Sep; 108(3 Suppl):10-5. PubMed ID: 19667525
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Preference comparison of rizatriptan ODT 10-mg and sumatriptan 50-mg tablet in migraine.
    Loder E, Brandes JL, Silberstein S, Skobieranda F, Bohidar N, Wang L, Boyle D, Kolodny A, Guerra F, Santanello N, Johnson-Pratt L, Rizatriptan Protocol 060 Study Group.
    Headache; 2001 Sep; 41(8):745-53. PubMed ID: 11576197
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Zolmitriptan intranasal: a review of the pharmacokinetics and clinical efficacy.
    Goadsby PJ, Yates R.
    Headache; 2006 Jan; 46(1):138-49. PubMed ID: 16412161
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pain-free rates with zolmitriptan 2.5 mg ODT in the acute treatment of migraine: results of a large double-blind placebo- controlled trial.
    Loder E, Freitag FG, Adelman J, Pearlmand S, Abu-Shakra S.
    Curr Med Res Opin; 2005 Mar; 21(3):381-9. PubMed ID: 15811207
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Improved migraine management in primary care: results of a patient treatment experience study using zolmitriptan orally disintegrating tablet.
    Shapero G, Dowson A, Lacoste JP, Almqvist P.
    Int J Clin Pract; 2006 Dec; 60(12):1530-5. PubMed ID: 17109663
    [Abstract] [Full Text] [Related]

  • 20. Fast relief from migraine attacks using fast-disintegrating sublingual zolmitriptan tablets.
    Mahmoud AA, Salah S.
    Drug Dev Ind Pharm; 2012 Jun; 38(6):762-9. PubMed ID: 22023340
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.